Stonebridge Financial Group (Pennsylvania)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Stonebridge Financial Group (Pennsylvania)'s BMY Position: Q2 2026 in Review
Stonebridge Financial Group (Pennsylvania) increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, buying an estimated $3.04K and bringing the position to 4,350 shares worth $251K. The position accounts for 0.02% of the portfolio, ranked #242.
Stonebridge Financial Group (Pennsylvania) first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $561K in Q1 2025. 2,147 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Stonebridge Financial Group (Pennsylvania) held 4,350 shares of Bristol-Myers Squibb worth $251K as of Q2 2026.
- Stonebridge Financial Group (Pennsylvania) bought 53 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.04K.
- Bristol-Myers Squibb made up 0.02% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #242 holding.
- Stonebridge Financial Group (Pennsylvania) first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Stonebridge Financial Group (Pennsylvania)'s Bristol-Myers Squibb position peaked at $561K in Q1 2025.
- 2,147 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.